Autopsy report · NCT02239354

A Safety, Tolerability, and Efficacy Study of VC-01™ Combination Product in Subjects With Type I Diabetes Mellitus

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Insufficient functional product engraftment”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 3 years 3 months before it stopped.
19 participants enrolled.
Results were posted on the registry 4 years 3 months after it ended.

Vital statistics

Status: Terminated
Phase: Phase 1, Phase 2
Sponsor: ViaCyte
Sponsor type: Industry
Conditions: Type 1 Diabetes Mellitus
Interventions: VC-01™ Combination Product
Participants: 19
Sites: 2
Countries: Canada, United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.